Schreiner MediPharm, a Germany-based provider of labels for the pharmaceutical industry, has developed an autoinjector label with special protection against abrasion for the allergy emergency drug epinephrine from Teva.
Patients suffering from life-threatening allergies, always carry a life-saving tool with them: an adrenaline autoinjector to use in the event of anaphylactic shock, countering an allergic reaction. Epinephrine is a prescription drug for the treatment of life-threatening allergic emergencies.
Teva offers the adrenaline in single-dose, prefilled disposable autoinjectors. The label developed by Schreiner MediPharm for this injector is provided with abrasion and scratch resistant reverse printing. As a result, it can withstand chemical and mechanical impacts.
Due to its special material construction and design precisely adapted to the autoinjector’s shape, the marking label securely adheres to the device. Thus, the vital product and user information is always reliably legible and readable. An additional cover protecting the label against abrasion or separation is not necessary, which reduces waste and environmental footprint. For product and patient safety, the label features a perforation that clearly and irreversibly indicates any first opening of the cap and any potential tampering attempt.
The label won recognition in the annual TLMI Competition, which awarded Schreiner MediPharm’s product development with second place in 2019’s Multi-Process category.